Eurofins Completes Acquisition of SYNLAB's Spanish Operations

Eurofins Scientific (EUFI.PA), a leader in bioanalytical testing, finalized the acquisition of SYNLAB's clinical diagnostics operations in Spain. The transfer was completed on March 31, 2025. This acquisition includes services such as genetics and anatomical pathology, which generated approximately €140 million in revenue in 2024.

The integration of SYNLAB's operations enhances Eurofins' existing Spanish network, spearheaded by Eurofins Megalab. This move positions Eurofins as a leading clinical diagnostics provider in Spain, serving public and private clients with a broad geographical reach.

Eurofins now has the capacity to serve over 10 million patients annually, delivering more than 100 million laboratory tests. Dr. Gilles Martin, Eurofins CEO, underscored the company's commitment to offering advanced services with this expansion.